Research Reflections: Braunstein Breaks Down Top ASCO 2020 Abstracts in Myeloma

In our exclusive interview, Marc J. Braunstein, MD, PhD, provides perspective on data in the upfront and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.

Read the full article here

Related Articles